4//SEC Filing
Howell Peyton R 4
Accession 0001438133-23-000106
CIK 0001438133other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:08 PM ET
Size
9.6 KB
Accession
0001438133-23-000106
Insider Transaction Report
Form 4
Howell Peyton R
Director
Transactions
- Exercise/Conversion
RSU 2023 05 24
2023-05-24+4,434→ 4,434 total→ Common Stock (4,434 underlying) - Exercise/Conversion
Common Stock
2023-05-25+2,757→ 11,307 total - Exercise/Conversion
Restricted Stock Unit
2023-05-25−2,757→ 0 total→ Common Stock (2,757 underlying)
Footnotes (6)
- [F1]Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F3]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- [F4]Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F5]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F6]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001528056
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:08 PM ET
- Size
- 9.6 KB